Toxin-antitoxin (TA) systems are prevalent and transcribed in clinical isolates of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
Autor: | Williams JJ; Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA., Halvorsen EM, Dwyer EM, DiFazio RM, Hergenrother PJ |
---|---|
Jazyk: | angličtina |
Zdroj: | FEMS microbiology letters [FEMS Microbiol Lett] 2011 Sep; Vol. 322 (1), pp. 41-50. Date of Electronic Publication: 2011 Jul 13. |
DOI: | 10.1111/j.1574-6968.2011.02330.x |
Abstrakt: | The percentage of bacterial infections refractory to standard antibiotic treatments is steadily increasing. Among the most problematic hospital and community-acquired pathogens are methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (PA). One novel strategy proposed for treating infections of multidrug-resistant bacteria is the activation of latent toxins of toxin-antitoxin (TA) protein complexes residing within bacteria; however, the prevalence and identity of TA systems in clinical isolates of MRSA and PA has not been defined. We isolated DNA from 78 MRSA and 42 PA clinical isolates and used PCR to probe for the presence of various TA loci. Our results showed that the genes for homologs of the mazEF TA system in MRSA and the relBE and higBA TA systems in PA were present in 100% of the respective strains. Additionally, reverse transcriptase PCR analysis revealed that these transcripts are produced in the clinical isolates. These results indicate that TA genes are prevalent and transcribed within MRSA and PA and suggest that activation of the toxin proteins could be an effective antibacterial strategy for these pathogens. (© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |